( NYSE:ABT )

News from Abbott A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 15, 2017, 08:00 ET North West London Pathology and Abbott Partner for Diagnostics Products and Services, including Alinity™, in Three NHS Trusts

North West London Pathology (NWLP), hosted by Imperial College Healthcare NHS Trust, and Abbott (NYSE: ABT) announced today that they signed a $252...


Aug 14, 2017, 08:00 ET Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.

Abbott (NYSE: ABT) announced today that it is extending its previously announced tender offer to purchase for cash all outstanding shares of Series...


Aug 10, 2017, 09:00 ET The Cost of Malnutrition: Study Shows Nutrition Program Could Save Hospitals up to $3,800 per Patient

Making sure people stay nourished in the hospital has shown to help patients recover, and real-world evidence confirms its cost benefits too. The...


Jul 20, 2017, 07:45 ET Abbott Reports Second-Quarter 2017 Results

Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2017. - Second-quarter worldwide sales of $6.6...


Jul 17, 2017, 08:17 ET Abbott Commences Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.

Abbott (NYSE: ABT) announced today that it is commencing a tender offer to purchase for cash all outstanding shares of Series B Convertible...


Jul 13, 2017, 07:30 ET Abbott and Bigfoot Biomedical Announce Collaboration to Develop Breakthrough Diabetes Technologies

Abbott (NYSE: ABT) and Bigfoot Biomedical today announced that the companies have entered into an agreement to develop and commercialize diabetes...


Jun 29, 2017, 13:32 ET Abbott Secures Health Canada License for FreeStyle® Libre System for People with Diabetes

Abbott (NYSE: ABT) today announced the Health Canada license of its FreeStyle® Libre Flash Glucose Monitoring System, a revolutionary new glucose...


Jun 21, 2017, 09:00 ET Abbott Hosts Conference Call for Second-Quarter Earnings

Abbott (NYSE: ABT) will announce its second-quarter 2017 financial results on Thursday, July 20, 2017, before the market opens. The announcement...


Jun 09, 2017, 10:15 ET Abbott Declares 374th Consecutive Quarterly Dividend

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 26.5 cents per share. This marks the 374th consecutive...


May 09, 2017, 09:00 ET Abbott Announces CE Mark for TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™

Abbott (NYSE: ABT) today announced CE Mark of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™, developed to make it easier for...


May 08, 2017, 09:00 ET Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor

Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm Rx™ Insertable Cardiac Monitor (ICM), the world's first smartphone...


May 08, 2017, 06:00 ET Abbott Announces National Reimbursement for FreeStyle® Libre in France, Providing Access to Revolutionary Technology for People with Diabetes

Abbott today announced that the French Health Ministry has granted national reimbursement across France for FreeStyle® Libre—Abbott's revolutionary...


Apr 26, 2017, 08:00 ET Abbott Introduces Science-Based Nutrition Drinks to Help Patients Have a Better Recovery from Surgery

More than 48 million surgeries happen in the U.S. each year,1 and for many of those patients, food is off the table in the hours prior to their...


Apr 19, 2017, 07:45 ET Abbott Reports First-Quarter 2017 Results

Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2017. - Reported diluted EPS from continuing...


Apr 14, 2017, 06:00 ET Abbott and Alere Amend Terms of Merger Agreement

Abbott (NYSE: ABT) and Alere Inc. (NYSE: ALR) announced today that the companies have agreed to amend the existing terms of their agreement for...


Mar 22, 2017, 09:00 ET Abbott Hosts Conference Call for First-Quarter Earnings

Abbott (NYSE: ABT) will announce its first-quarter 2017 financial results on Wednesday, April 19, 2017, before the market opens. The...


Mar 19, 2017, 14:00 ET Late-Breaking Data Shows the CardioMEMS HF System is Effective in Reducing Heart Failure Hospitalizations and Cost of Care

New late-breaking featured clinical research presented today adds strong clinical support for Abbott's CardioMEMS™ HF System as an effective...


Mar 18, 2017, 12:30 ET Late-Breaking Data on Abbott's MitraClip® System Show Continued Benefit for People with Mitral Regurgitation, Most Common Heart Valve Disease

Abbott (NYSE: ABT) today announced favorable one-year outcomes from the largest study of real-world experience for the MitraClip system in...


Mar 08, 2017, 16:15 ET Abbott to Present at Barclays Capital 2017 Global Healthcare Conference

Abbott (NYSE: ABT) will present at the Barclays Capital Global Healthcare Conference on Thursday, March 16, 2017. Brian Yoor, executive vice...


Mar 08, 2017, 09:00 ET New Study Results May Lead to a New Standard of Care for In Vitro Fertilization Treatment

New study results published in Human Reproduction could pave the way for an additional treatment option for the estimated 1.5 million women...


Mar 07, 2017, 09:00 ET Abbott Announces Results of Early Tenders and Consents in Exchange Offers and Execution of Supplemental Indenture

Abbott (NYSE: ABT) announced today that, as of 5:00 p.m. New York City time, on March 6, 2017, the aggregate principal amounts of each series of...


Feb 21, 2017, 08:55 ET Abbott Commences Exchange Offers and Consent Solicitations for St. Jude Medical, LLC Notes

Abbott (NYSE:ABT) announced today that it has commenced offers to exchange all validly tendered and accepted notes of the following series issued...


Feb 17, 2017, 11:25 ET Abbott Declares 373rd Consecutive Quarterly Dividend

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 26.5 cents per share. This marks the 373rd consecutive...


Feb 15, 2017, 08:30 ET Real-World Data from Abbott's FreeStyle® Libre Show Association Between Higher Frequency of Glucose Monitoring and Improved Glucose Control for People with Diabetes

Abbott (NYSE: ABT) today announced the results of real-world use data[1] showing that people who scan more frequently using Abbott′s FreeStyle®...


Feb 02, 2017, 08:00 ET U.S. FDA Grants Abbott the First Commercial Authorization for a Molecular Test to Detect Zika Virus Using Whole Blood

Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has authorized its molecular test, the Abbott RealTime ZIKA...